Roger Hodge
Internal Medicine · Nashville, TNNPI 1255370029
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,156 and has fallen 65.6% since, to $398 in 2021.
Across 162 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$483
- Pfizer$218
- Amgen$208
- AbbVie$186
- Arbor Pharmaceuticals, Inc.$183
- GSK$143
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,58499%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $483 |
| Pfizer | 13 | $218 |
| Amgen | 13 | $208 |
| AbbVie | 13 | $186 |
| Arbor Pharmaceuticals, Inc. | 11 | $183 |
| GSK | 10 | $143 |
| Astellas Pharma US Inc | 10 | $142 |
| AstraZeneca | 9 | $137 |
| Sanofi-aventis U.S. LLC | 9 | $135 |
| Johnson & Johnson(2 entities) | 6 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $114 |
| Eisai Inc. | 6 | $91 |
| Amarin Pharma, Inc. | 6 | $91 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $48 |
| Supernus Pharmaceuticals, Inc. | 3 | $43 |
| Merck | 2 | $40 |
| Biohaven Pharmaceuticals, Inc. | 2 | $28 |
| Novartis | 2 | $26 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Gilead | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Bardy Diagnostics, Inc. | 2 | $16 |
| Assertio Therapeutics, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
How this compares
$2,614 in reported general payments places this provider in the 80th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Nashville
- John AndersonNashville$1.5M
- Temidayo AbeNashville$113K
- Wayne RileyNashville$86K
- Leah CordovezNashville$64K
- Asad Al AboudNashville$44K
- Mark KouryNashville$41K
- David HeusinkveldNashville$24K
- Charlotte LohreyNashville$19K
- Malek Al-OmaryNashville$18K
- James GekasNashville$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.